Ascentage Pharma Group International logo

Ascentage Pharma Group International

HKEX:6855.HK

Overview | Financials
Company Name Ascentage Pharma Group International
Symbol 6855.HK
Currency HKD
Price 44.2
Market Cap 13,855,570,911
Dividend Yield 0%
52-week-range 15.42 - 48.85
Industry Biotechnology
Sector Healthcare
CEO Dr. Dajun Yang M.D., Ph.D.
Website https://www.ascentagepharma.com

An error occurred while fetching data.

About Ascentage Pharma Group International

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation, as well as for patients

Related Stocks

Consun Pharmaceutical Group Limited logo

Consun Pharmaceutical Group Limited

1681.HK

8.66 HKD

Hua Medicine (Shanghai) Ltd. logo

Hua Medicine (Shanghai) Ltd.

2552.HK

1.77 HKD

Town Health International Medical Group Limited logo

Town Health International Medical Group Limited

3886.HK

0.255 HKD

Zylox-Tonbridge Medical Technology Co., Ltd. logo

Zylox-Tonbridge Medical Technology Co., Ltd.

2190.HK

11.02 HKD

Sisram Medical Ltd logo

Sisram Medical Ltd

1696.HK

3.63 HKD

Ascletis Pharma Inc. logo

Ascletis Pharma Inc.

1672.HK

1.62 HKD

MicroTech Medical (Hangzhou) Co., Ltd. logo

MicroTech Medical (Hangzhou) Co., Ltd.

2235.HK

4.6 HKD

Peijia Medical Limited logo

Peijia Medical Limited

9996.HK

3.83 HKD

China Pioneer Pharma Holdings Limited logo

China Pioneer Pharma Holdings Limited

1345.HK

2.03 HKD

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. logo

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

1558.HK

8.98 HKD

Financials

Numbers are in millions USD

Numbers are in millions USD